Skip to content
★ Sign in to follow
GB

Gordon Brandt

Marina Biotech, Inc.
Total declarations
33
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (13 ops.)
€661k

Latest filing published 02 Apr 2008 for Marina Biotech, Inc., €1,532.

Insider track record

Disclosed buys
0
Disclosed sells
13
Signal history

No signal scores available.

Gordon Brandt: trading record in brief

Gordon Brandt discloses dealings in Marina Biotech, Inc. to SEC (Form 4). Over a trading history stretching from 23 January 2006 to 1 April 2008, the count stands at 33 filings.

Sales make up the whole of the open-market record (13 sales, €661k). Besides market trades, the filings include 5 share grants and 14 option exercises.

The newest entry dates from 2 April 2008: a transaction of €1,532, in Marina Biotech, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Gordon Brandt

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations33 total
  • ●
    PresidentExecutivesMarina Biotech, Inc.
    2,402 USD0SEC
    1,201 shares@ US$2.00Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-08-021814:0
  • ◆
    PresidentExecutivesMarina Biotech, Inc.
    2,380 USD0SEC
    661 shares@ US$3.60Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-071181:0
  • ◆
    PresidentExecutivesMarina Biotech, Inc.
    0SEC
    18,000 shares0Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-071181:1
  • ◇
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    54,950 USD0SEC
    5,000 shares@ US$10.99Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-025228:0
  • ▼
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    66,100 USD0SEC
    5,000 shares@ US$13.22Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-025228:1
  • ◆
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    0SEC
    12,000 shares0Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-008727:0
  • ◇
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    29,630 USD0SEC
    3,333 shares@ US$8.89Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-008727:1
  • ◇
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    17,320 USD0SEC
    1,667 shares@ US$10.39Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-008727:2
  • ▼
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    65,600 USD0SEC
    5,000 shares@ US$13.12Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-008727:3
  • ◆
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    8,785 USD0SEC
    660 shares@ US$13.31Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-004907:0
  • ◇
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    44,450 USD0SEC
    5,000 shares@ US$8.89Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-002457:0
  • ▼
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    73,450 USD0SEC
    5,000 shares@ US$14.69Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-002457:1
  • ▼
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    10,577 USD0SEC
    675 shares@ US$15.67Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-066821:0
  • ◇
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    54,950 USD0SEC
    5,000 shares@ US$10.99Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-063563:0
  • ▼
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    80,900 USD0SEC
    5,000 shares@ US$16.18Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-063563:1
  • ◇
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    54,950 USD0SEC
    5,000 shares@ US$10.99Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-057725:0
  • ▼
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    82,250 USD0SEC
    5,000 shares@ US$16.45Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-057725:1
  • ◇
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    54,950 USD0SEC
    5,000 shares@ US$10.99Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-053861:0
  • ▼
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    75,700 USD0SEC
    5,000 shares@ US$15.14Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-053861:1
  • ◇
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    54,950 USD0SEC
    5,000 shares@ US$10.99Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-049263:0
  • ▼
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    75,500 USD0SEC
    5,000 shares@ US$15.10Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-049263:1
  • ◇
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    14,820 USD0SEC
    1,667 shares@ US$8.89Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-044537:0
  • ◇
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    25,975 USD0SEC
    2,500 shares@ US$10.39Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-044537:1
  • ◇
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    9,155 USD0SEC
    833 shares@ US$10.99Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-044537:2
  • ▼
    Exec VP of Science and ClinicaExecutivesMarina Biotech, Inc.
    69,250 USD0SEC
    5,000 shares@ US$13.85Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-044537:3

25 of 33 declarations